Financiere de Tubize SA
XBRU:TUB

Watchlist Manager
Financiere de Tubize SA Logo
Financiere de Tubize SA
XBRU:TUB
Watchlist
Price: 141.6 EUR -1.94% Market Closed
Market Cap: 6.3B EUR
Have any thoughts about
Financiere de Tubize SA?
Write Note

Relative Value

The Relative Value of one TUB stock under the Base Case scenario is 0.22 EUR. Compared to the current market price of 141.6 EUR, Financiere de Tubize SA is Overvalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TUB Relative Value
Base Case
0.22 EUR
Overvaluation 100%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
0
Median 3Y
15.3
Median 5Y
11.3
Industry
2.6
vs History
9
vs Industry
8
Median 3Y
11.1
Median 5Y
11.1
Industry
23
vs History
0
vs Industry
Median 3Y
-2 579.1
Median 5Y
-2 356.3
Industry
17.8
vs History
vs Industry
Median 3Y
-97
Median 5Y
-54.4
Industry
25.4
vs History
0
vs Industry
30
Median 3Y
1.1
Median 5Y
1.1
Industry
2.2
vs History
vs Industry
0
Median 3Y
15.3
Median 5Y
11.3
Industry
2.8
vs History
vs Industry
0
Median 3Y
9.9
Median 5Y
10.3
Industry
5.4
vs History
vs Industry
100
Median 3Y
8.6
Median 5Y
9.6
Industry
13.7
vs History
vs Industry
0
Median 3Y
8.6
Median 5Y
9.6
Industry
17.2
vs History
0
vs Industry
Median 3Y
-2 565.4
Median 5Y
-2 355.9
Industry
16.5
vs History
0
vs Industry
Median 3Y
-2 565.4
Median 5Y
-2 355.9
Industry
19.3
vs History
0
vs Industry
30
Median 3Y
1.1
Median 5Y
1.1
Industry
2

Multiples Across Competitors

TUB Competitors Multiples
Financiere de Tubize SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BE
Financiere de Tubize SA
XBRU:TUB
6.3B EUR 0 34.3 -3 105.8 -3 105.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
746.8B USD 18.3 89.2 48 53.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
365.6B USD 4.2 24.9 12 15.7
US
Merck & Co Inc
NYSE:MRK
249.1B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.6B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.4 169.3 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
BE
Financiere de Tubize SA
XBRU:TUB
Average P/E: 33.3
34.3
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.2
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.9
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top